SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-22-033720
Filing Date
2022-03-15
Accepted
2022-03-15 09:26:06
Documents
3
Period of Report
2022-03-14

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm228459d3_6k.htm 6-K 14882
2 EXHIBIT 99.1 tm228459d3_ex99-1.htm EX-99.1 13871
3 GRAPHIC tm228459d3_ex99-1img01.jpg GRAPHIC 20729
  Complete submission text file 0001104659-22-033720.txt   58438
Mailing Address BREDGADE 34E COPENHAGEN K G7 1260
Business Address BREDGADE 34E COPENHAGEN K G7 1260 4531262615
Evaxion Biotech A/S (Filer) CIK: 0001828253 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39950 | Film No.: 22739347
SIC: 2836 Biological Products, (No Diagnostic Substances)